Black Rose Industries Limited · BSE:BLACKROSE
Black Rose Industries — Q1 FY23 Earnings Presentation
17 slides from Black Rose Industries's earnings presentation, Aug 18, 2022
Slide 1: Black Rose Industries Q1 FY23 Earnings Webinar
BLACK ROSE INDUSTRIES LTD. Q1 FY23 EARNINGS WEBINAR August 18, 2022 Mr. Anup Jatia – Executive Director Mr. Ambarish Daga – Joint CFO and Investor Relations Officer August 24, 2021
Slide 2: Disclaimer
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by BLACK ROSE INDUSTRIES LTD. (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendatio
Slide 3: Business presence of Black Rose
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Polyacrylamide Business presence solid - 10,000 MTPA of Black Rose Acrylamide liquid – (in R&D) N-methylol 32,000 MTPA acrylamide (NMA) - 2,000 Chemical (20,000 MTPA for merchant MTPA distribution sales and 12,000 MTPA for Chemical captive requirem
Slide 4: Financials – Profit & Loss (Standalone & Consolidated)
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials – Profit & Loss (Standalone & Consolidated) INR. in millions STANDALONE CONSOLIDATED Particulars Q1 FY23 Q4 FY22 Change % Q1 FY23 Q4 FY22 Change % Revenue from operations 660.24 868.91 -24% 1198.61 1345.03 -11% EBITDA 57.35 74.84 -23% 66
Slide 5: Financials – Balance Sheet (Standalone & Consolidated)
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials – Balance Sheet (Standalone & Consolidated) INR in millions All ratios on basis of Standalone figures STANDALONE CONSOLIDATED Return on Equity (%) Particulars Q1 FY23 Q4 FY22 Q1 FY23 Q4 FY22 Sources of Funds 15.00% Equity Share Capital 5
Slide 6: Financials – (Standalone)
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials – (Standalone) Total revenue and EBITDA INR in millions Highlights 1,000 100 874 900 • Profitability affected by lower price R 800 663 75 E realisation in acrylamide and E 700 V 600 75 B resorcinol I E N 500 57 50 T • Reduction in revenu
Slide 7: Financials – Revenue and geographic mix
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials – Revenue and geographic mix 1% 1% MANUFACTURING 33 39 % % DISTRIBUTION 66 60 % % OTHERS Q4 FY22 Q1 FY23 10 8% % EXPORTS LOCAL 92 90 % % Figures rounded off to closest unit percentage 7
Slide 8: Financials - Distribution
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials - Distribution Total distribution revenue and EBITDA Highlights 600 INR in millions 50 • The overall revenue from the distribution segment was down by 500 39 40 31% from the previous quarter 400 27 • EBITDA margin unchanged over 30 previ
Slide 9: Financials - Manufacturing
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Financials - Manufacturing Total manufacturing revenue and EBITDA Highlights INR in millions • Overall revenue decreased by 11% 300 60 compared to previous quarter 46 50 • Acrylamide prices declined due to 41 spillover effect of market 200 40 slowd
Slide 10: Acrylonitrile – Acrylamide Price Trend
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Acrylonitrile – Acrylamide Price Trend ACN- Acrylamide Price Trend 2,338 2,233 2,400 2,200 2,203 2,206 2,173 110 2,155 2,167 2,253 2,318 2,300 1,850 2,230 1,970 1,820 2,000 2,150 1,835 1,838 100 Acrylamide PriceRs/kg 1,948 1,930 1,600 1,810 1,856 1
Slide 11: Outlook for the current quarter: Chemical distribution, and manufacturing
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Outlook for the current quarter: Chemical distribution, and manufacturing Chemical distribution Business expected to be subdued. There is an oversupply position in the market due to the low offtake in the previous months Expect increase in dema
Slide 12: Outlook for the current quarter: Chemical distribution, and manufacturing
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Outlook for the current quarter: Chemical distribution, and manufacturing Acrylamide liquid and solid Domestic market to be subdued during Q2 FY23. Expect recovery by end September with improvement in Chinese domestic market conditions Exports
Slide 13: Outlook for the current quarter: Chemical distribution, and manufacturing
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Outlook for the current quarter: Chemical distribution, and manufacturing PAM Liquid N-methylol acrylamide (NMA) Sales during Q2 FY23 is expected to be low due Product approvals from key clients have started to shutdown declared by Morbi cerami
Slide 14: Outlook for the current quarter: Chemical distribution, and manufacturing
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Outlook for the current quarter: Chemical distribution, and manufacturing Polyacrylamide Solid Polycarboxylate Acid Induction of R&D/technical advisor from Japan Currently in R&D phase, expecting finalization completed in July during Q3 FY23
Slide 15: Focus on R&D
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Outlook for the current quarter: Chemical distribution, and manufacturing Focus on R&D Setting up new world class R&D centre in the outskirts of Mumbai for product and application development Focus on green chemistries for production of traditi
Slide 16: Manufacturing business Capacities and CAPEX
INVESTOR Q1 PRESENTATION FY23FY2021-22 EARNINGS 2020 WEBINAR Manufacturing business Capacities and CAPEX Product Capacity CAPEX in Rs. Incurred in Technology Further Available MTPA Crores* Rs. Crores* possibility capacity for MTPA growth Acrylamide (L) 20,000 + 41 MCI 60,000 30% 12,000 Polyacrylamid
Slide 17: Contact
INVESTOR Q1 PRESENTATION FY23 EARNINGS WEBINAR 2020 Contact Mr. Ambarish Daga Joint CFO & Investor Relations Officer Head office 145/A, Mittal Towers Nariman Point, Mumbai 400 021, India Call / Fax +91-22-4333-7200 +91-22-2287-3022 (Fax) Mail to [email protected]
Black Rose Industries — Q1 FY23 Earnings Presentation on 6ix